Purchase Order VA26015P0818

This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO). The $1,340,461.88 firm fixed-price delivery order is for a clinical trial to assess the safety, tolerability, and pharmacokinetics of an investigational agent for substance use disorder (SUD) treatment. The contract is part of NIDA's $21 million indefinite delivery contract N01DA-23-8935, which supports...

This is a delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian federal agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $415,717.00 contract is for a Phase I Single Ascending Dose Study under NIDA's Pharmacokinetic Analysis Resource Center program. The work will be performed in Westlake, Maryland from September 10, 2024 to March 9, 2026. This contract is not set aside and is a...

Technical Resources International, Inc. (TRI) has been awarded a firm fixed price purchase order valued at one million six hundred twenty four thousand one hundred twenty two dollars and twenty cents ($1,624,122.20) by the Department of Health and Human Services' Food and Drug Administration (FDA) to assess nicotine dose discrimination in marketed cigarettes. This purchase order was issued under an indefinite delivery/indefinite quantity contract held by TRI with the National Institutes of...

This is a Delivery Order under the "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite Delivery Indefinite Quantity (IDIQ) contract, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Duke University. The contract is for administrative and overall clinical operations support under NIDA's Phase I clinical trials program for developing neurotherapeutics. The fixed-price delivery order has a ceiling value of $409,541.00 and a period of...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,570,341 purchase order to Antelope Flats, LLC to provide targeted participant marketing and advertising services in support of clinical research studies conducted by NIDA's Intramural Research Program. The solicitation sought proposals to develop customized recruitment strategies and campaigns for each protocol to enroll eligible research participants, including those with...

The Research Triangle Institute - doing business as RTI International - has been awarded a $1,297,307 cost plus fixed fee delivery order contract by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to provide preparation and distribution of research drug products from March 20, 2022 through March 19, 2023. The prime contractor RTI International will utilize its facilities in Research Triangle Park, North Carolina to fulfill the task order...

The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $1,183,250.00 cost-plus-fixed-fee Delivery Order contract to Research Triangle Institute (RTI International), a non-profit research organization, for the Preparation and Distribution of Research Drug Products. The contract period of performance is March 20, 2025 to March 19, 2029. This Delivery Order contract is likely part of a larger Indefinite Delivery Vehicle (IDV) that NIDA utilizes to efficiently procure these...

This is a $3,265,588.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization. The contract is for a first-in-human randomized, double-blind, placebo-controlled single ascending dose (SAD) Phase I study on the development of neurotherapeutics. The contract is not set aside and is...

The National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, has awarded a firm fixed-price purchase order to La Jolla Alcohol Research, Inc., a small disadvantaged business, to provide 16 additional vapor self-administration chambers for $110,000.00. This sole-source contract supports NIDA's research on brain circuits and areas involved in drug addiction, reward, and aversion. The chambers will be used for studies comparing sex and strain...

The Food and Drug Administration (FDA) awarded a $2,370,057 firm fixed price definitive contract to Altasciences Clinical Kansas Inc., a contract research organization, for a dose-finding pilot study of kratom alkaloids to be conducted in Silver Spring, Maryland through September 2024. This award was not set aside under any small business programs. Altasciences has prior experience providing clinical pharmacology research services to federal agencies, including a $1.8 million firm fixed price...